Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Equity Income (2024 - 2025)

PAVmed (PAVM) has 2 years of Equity Income data on record, last reported at -$4.4 million in Q3 2025.

  • For Q3 2025, Equity Income changed N/A year-over-year to -$4.4 million; the TTM value through Sep 2025 reached $6.1 million, changed N/A, while the annual FY2024 figure was $532000.0, N/A changed from the prior year.
  • Equity Income reached -$4.4 million in Q3 2025 per PAVM's latest filing, up from -$10.6 million in the prior quarter.
  • Across five years, Equity Income topped out at $21.0 million in Q1 2025 and bottomed at -$10.6 million in Q2 2025.